Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P31749 (
AKT
)
22,954
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Insulin
activated endogenous
protein kinase B alpha
(also known as RAC/Akt kinase) activity 12-fold in L6 myotubes, while after transfection into 293 cells PKBalpha was activated 20- and 50-fold in response to
insulin
and IGF-1 respectively. In both cells, the activation of PKBalpha was accompanied by its phosphorylation at Thr308 and Ser473 and, like activation, phosphorylation of both of these residues was prevented by the phosphatidylinositol 3-kinase inhibitor wortmannin. Thr308 and/or Ser473 were mutated to Ala or Asp and activities of mutant PKBalpha molecules were analysed after transfection into 293 cells. The activity of wild-type and mutant PKBalpha was also measured in vitro after stoichiometric phosphorylation of Ser473 by MAPKAP kinase-2. These experiments demonstrated that activation of PKBalpha by
insulin
or insulin-like growth factor-1 (IGF-1) results from phosphorylation of both Thr308 and Ser473, that phosphorylation of both residues is critical to generate a high level of PKBalpha activity and that the phosphorylation of Thr308 in vivo is not dependent on phosphorylation of Ser473 or vice versa. We propose a model whereby PKBalpha becomes phosphorylated and activated in
insulin
/IGF-1-stimulated cells by an upstream kinase(s).
...
PMID:Mechanism of activation of protein kinase B by insulin and IGF-1. 897 81
Insulin
stimulated
protein kinase B alpha
(PKB alpha) more than 10-fold and decreased glycogen synthase kinase-3 (GSK3) activity by 50 +/- 10% in skeletal muscle and adipocytes. Rapamycin did not prevent the activation of PKB, inhibition of GSK3 or stimulation of glycogen synthase up to 5 min. Thus rapamycin-insensitive pathways mediate the acute effect of
insulin
on glycogen synthase in the major
insulin
-responsive tissues. The small and very transient effects of EGF on phosphatidylinositol (3,4,5)P3 PKB alpha and GSK3 in adipocytes, compared to the strong and sustained effects of
insulin
, explains why EGF does not stimulate glucose uptake or glycogen synthesis in adipocytes.
...
PMID:Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. 910 20
Protein kinase B
(
PKB
) (also referred to as RAC/Akt kinase) has been shown to be controlled by various growth factors, including
insulin
, using cell lines and transfected cells. However, information is so far scarce regarding its regulation in primary
insulin
-responsive cells. We have therefore used isolated rat adipocytes to examine the mechanisms, including membrane translocation, whereby
insulin
and the
insulin
-mimicking agents vanadate and peroxovanadate control
PKB
. Stimulation of adipocytes with
insulin
, vanadate, or peroxovanadate caused decreased
PKB
mobility on sodium dodecyl sulfate-polyacrylamide gels, indicative of increased phosphorylation, which correlated with an increase in kinase activity detected with the peptide KKRNRTLTK. This peptide was found to detect activated
PKB
selectively in crude cytosol and partially purified cytosol fractions from
insulin
-stimulated adipocytes. The decrease in electrophoretic mobility and activation of
PKB
induced by
insulin
was reversed both in vitro by treatment of the enzyme with alkaline phosphatase and in the intact adipocyte upon removal of
insulin
or addition of the phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor wortmannin. Significant translocation of
PKB
to membranes could not be demonstrated after
insulin
stimulation, but peroxovanadate, which appeared to activate PI 3-kinase to a higher extent than
insulin
, induced substantial translocation. The translocation was prevented by wortmannin, suggesting that PI 3-kinase and/or the 3-phosphorylated phosphoinositides generated by PI 3-kinase are indeed involved in the membrane targeting of
PKB
.
...
PMID:Regulation of protein kinase B in rat adipocytes by insulin, vanadate, and peroxovanadate. Membrane translocation in response to peroxovanadate. 926 Nov 71
PI3K was originally discovered as a lipid kinase involved in the phosphorylation of the inositol ring in position -3, leading to the synthesis of phosphatidyl-inositol-3-4 bisphosphate. The enzyme purified from rat liver is an heterodimer of two subunits of 85 and 110 KD respectively: it phosphorylates the D3 hydroxyl of phosphoinositides to produce phosphatidyl-inositol-3-phosphate. So far the function of the 3-phospho-inositide is unclear. It is likely that the entire phospholipid serves as a second messenger, since no phospholipase C has yet been found that can cleave the inositol group with a 3 phosphate residue. However the activation targets of this second messenger are still poorly known. Recently a novel/serine/theronine kinase was insolated by three groups and called differently RAC, PKB and
AKT
. It exhibits sequence homology with protein kinase A and C at the carboxyl terminal, whereas the aminoterminal domain has a plectrin homology. Activation of ATK is inhibited by wortmannin, a specific inhibitor of PI3K at very low concentrations. Furthermore inositol-3-phosphate can activate ATK in vitro. In addition very recently, a linkage of G-protein coupled receptors to the MAP kinase signalled pattern through PI3K has been discovered. But what is downstream of this pathway? 70S6 kinase is an attractive candidate since this kinase, involved in protein synthesis, is activated by
AKT
in vivo. Interestingly
AKT
is the cellular protooncogene of v-ATK and this implies that ATK induces a pathway of oncogenic transformation.
AKT
is inhibited by dominant negative mutants of ras and thus involved in the ras-raf-MAP kinase pathway. The role of PI3K is still indefinite but it must have a paramount importance in cell signalling since nearly all growth factor receptors recruit this enzyme and that the activity of fundamental growth factor receptors like PDGF, EGF and
insulin
are blocked by the specific inhibitor wortmannin, leading to the conclusion that the PI3K signal is much important in mitogenesis, protein synthesis, membrane ruffling, cell transformation and cell cycle progression.
...
PMID:PI3K signal and DNA repair: a short commentary. 926 40
Activated insulin receptor (IR) interacts with its substrates, IRS-1, IRS-2, and Shc via the NPXY motif centered at Y960. This interaction is important for IRS-1 phosphorylation. Studies using the yeast two-hybrid system and sequence identity analysis between IRS-1 and IRS-2 have identified two putative elements, the PTB and SAIN domains, between amino acids 108 and 516 of IRS-1 that are sufficient for receptor interaction. However, their precise function in mediating
insulin
's bioeffects is not understood. We expressed the PTB and SAIN domains of IRS-1 in HIRcB fibroblasts and 3T3-L1 adipocytes utilizing replication-defective adenoviral infection to investigate their role in
insulin
signalling. In both cell types, overexpression of either the PTB or the SAIN protein caused a significant decrease in
insulin
-induced tyrosine phosphorylation of IRS-1 and Shc proteins, IRS-1-associated phosphatidylinositol 3-kinase (PI 3-K) enzymatic activity, p70s6k activation, and p44 and p42 mitogen-activated protein kinase (MAPK) phosphorylation. However, epidermal growth factor-induced Shc and MAPK phosphorylation was unaffected by the overexpressed proteins. These findings were associated with a complete inhibition of
insulin
-stimulated cell cycle progression. In 3T3-L1 adipocytes, PTB or SAIN expression extinguished IRS-1 phosphorylation with a corresponding 90% decrease in IRS-1-associated PI 3-K activity. p70s6k is a downstream target of PI 3-K, and
insulin
-stimulated p70s6k was inhibited by PTB or SAIN expression. Interestingly, overexpression of either PTB or SAIN protein did not affect
insulin
-induced
AKT
activation or
insulin
-stimulated 2-deoxyglucose transport, even though both of these bioeffects are inhibited by wortmannin. Thus, interference with the IRS-1-IR interaction inhibits
insulin
-stimulated IRS-1 and Shc phosphorylation, PI 3-K enzymatic activity, p70s6k activation, MAPK phosphorylation and cell cycle progression. In 3T3-L1 adipocytes, interference with the IR-IRS-1 interaction did not cause inhibition of
insulin
-stimulated
AKT
activation or glucose transport. These results indicate a bifurcation or subcompartmentalization of the
insulin
signalling pathway whereby some targets of PI 3-K (i.e., p70s6k) are dependent on IRS-1-associated PI 3-K and other targets (i.e.,
AKT
and glucose transport) are not. IR-IRS-1 interaction is not essential for
insulin
's effect on glucose transport, and alternate, or redundant, pathways exist in these cells.
...
PMID:Adenovirus-mediated overexpression of IRS-1 interacting domains abolishes insulin-stimulated mitogenesis without affecting glucose transport in 3T3-L1 adipocytes. 937 69
293 cells were transfected with wild-type GSK3beta (WT-GSK3beta) or a mutant in which the PKB phosphorylation site (Ser-9) was altered to Ala (A9-GSK3beta). Upon stimulation with IGF-1 or
insulin
, WT-GSK3beta was inhibited 75% or 60%, respectively, whereas the activity of the A9-GSK3beta mutant was unaffected. Incubation of WT-GSK3beta with PP2A1 (a Ser/Thr-specific phosphatase) completely reversed the IGF-1- or
insulin
-induced inhibition. IGF-1 stimulation did not induce any tyrosine dephosphorylation of WT-GSK3beta or A9-GSK3beta. Coexpression of WT-GSK3beta in 293 cells with either PKB alpha (also known as
AKT
) or PDK1 (the 'upstream' activator of PKB) mimicked the IGF-1- or
insulin
-induced phosphorylation of Ser-9 and inactivation of GSK3beta.
...
PMID:Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. 937 75
Insulin
regulates the expression of multiple hepatic genes through a conserved
insulin
response sequence (IRS) (CAAAAC/TAA) by an as yet undetermined mechanism.
Protein kinase B
/Akt (PKB/Akt), a member of the PKA/PKC serine/threonine kinase family, functions downstream from phosphatidylinositol 3'-kinase (PI3K) in mediating effects of
insulin
on glucose transport and glycogen synthesis. We asked whether PKB/Akt mediates sequence-specific effects of
insulin
on hepatic gene expression using the model of the insulin-like growth factor binding protein-1 (IGFBP-1) promoter.
Insulin
lowers IGFBP-1 mRNA levels, inhibits IGFBP-1 promoter activity, and activates PKB/Akt in HepG2 hepatoma cells through a PI3K-dependent, rapamycin-insensitive mechanism. Constitutively active PI3K and PKB/Akt are each sufficient to mediate effects of
insulin
on the IGFBP-1 promoter in a nonadditive fashion. Dominant negative K179 PKB/Akt disrupts the ability of
insulin
and PI3K to activate PKB/Akt and to inhibit promoter activity. The IGFBP-1 promoter contains two IRSs each of which is sufficient to mediate sequence-specific effects of
insulin
, PI3K, and PKB/Akt on promoter activity. Highly related IRSs from the phosphoenolpyruvate carboxykinase and apolipoprotein CIII genes also are effective in this setting. These results indicate that PKB/Akt functions downstream from PI3K in mediating sequence-specific effects of
insulin
on the expression of IGFBP-1 and perhaps multiple hepatic genes through a conserved IRS.
...
PMID:Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. 949 82
Protein kinase B
(
PKB
)/Akt is a growth-factor-regulated serine/threonine kinase which contains a pleckstrin homology domain. Binding of phosphoinositide 3-OH kinase products to the pleckstrin homology domain results in translocation of
PKB
/Akt to the plasma membrane where it is activated by phosphorylation by upstream kinases including the phosphoinoside-dependent kinase 1 (PDK1). Activated
PKB
/Akt provides a survival signal that protects cells from apoptosis induced by various stresses, and also mediates a number of metabolic effects of
insulin
.
...
PMID:Mechanisms and consequences of activation of protein kinase B/Akt. 956 51
Both
insulin
and muscle contraction stimulate glucose transport activity. However, contraction stimulation does not involve the
insulin
signalling intermediate phosphatidylinositol 3-kinase (PI 3-kinase).
Protein kinase B
(
PKB
) has recently been identified as a direct downstream target of PI 3-kinase in the
insulin
signalling pathway. We have examined here whether the two stimuli share
PKB
as a convergent step in separate signalling pathways.
Insulin
stimulates both glucose transport, GLUT4 cell-surface content and
PKB
activity (by 4-6-fold above basal) in a wortmannin-sensitive manner in in vitro incubated rat soleus muscles. By contrast, muscle contraction, which stimulates glucose transport and the cell surface content of GLUT4 by 3-fold above basal levels, had no effect on
PKB
activity. These data demonstrate that
PKB
is not a mediator of contraction-induced glucose transport and GLUT4 translocation.
...
PMID:Evidence against protein kinase B as a mediator of contraction-induced glucose transport and GLUT4 translocation in rat skeletal muscle. 956 15
Protein kinase B
(
PKB
) has previously been shown to be activated in response to
insulin
and growth factor stimulation. The activation mechanism has been suggested to involve translocation of
PKB
to membranes, where it is phosphorylated and activated.
Insulin
-induced translocation of
PKB
has not been demonstrated in a physiological target cell. Therefore we have used the primary rat adipocyte to investigate
insulin
-induced translocation of
PKB
. In the presence of 1 nM
insulin
translocation of
PKB
was detected within 30 seconds and was blocked by wortmannin, a selective phosphatidylinositol 3-kinase inhibitor. This translocation was potentiated by the tyrosine phosphatase inhibitor vanadate. Subcellular localization studies revealed that
PKB
translocated to the plasma membrane.
...
PMID:Insulin-induced translocation of protein kinase B to the plasma membrane in rat adipocytes. 960 Jan 1
1
2
3
4
5
6
7
8
9
10
Next >>